<DOC>
	<DOCNO>NCT00555347</DOCNO>
	<brief_summary>To determine effect Armodafinil ( Nuvigil ) fatigue sleep sarcoidosis .</brief_summary>
	<brief_title>Use Armodafinil Fatigue Sarcoidosis</brief_title>
	<detailed_description>The study divide two half . Patients receive either drug placebo first half . Patients receive active drug start one dose increase second visit . Those patient randomize placebo also dose adjust investigate physician . The physician blind whether patient receive drug placebo . In second half study , patient receive opposite treatment . Patients complete detailed questionnaire regard fatigue , sleepiness , overall quality life . They sleep study do start half study determine effect therapy sleepiness .</detailed_description>
	<mesh_term>Fatigue</mesh_term>
	<mesh_term>Sarcoidosis</mesh_term>
	<mesh_term>Armodafinil</mesh_term>
	<mesh_term>Modafinil</mesh_term>
	<criteria>Diagnosis sarcoidosis use standard criterion 15 . Disease one year On stable , systemic therapy Complain fatigue present six month . Over 18 year age Provide write informed consent . Pregnancy Change therapy sarcoidosis prior three month History ventricular arrythmias</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Sarcoidosis</keyword>
	<keyword>Fatigue</keyword>
</DOC>